Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Poly Medicure Ltd.
Swot
Poly Medicure Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Poly Medicure Ltd. has 15 Strengths, 9 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(9)
Opportunity
(5)
Threats
(1)
Others
(2)
Positive Breakout First Resistance ( LTP > R1)
Benjamin Graham Value Screen
Consistent Highest Return Stocks over Five Years
Companies with high TTM EPS Growth
Expensive Performers (DVM)
PEG lower than Industry PEG
Increasing Revenue every Quarter for the past 8 Quarters
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
High PE (PE > 40)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Weak Momentum: Price below Short, Medium and Long Term Averages
Increasing Trend in Non-Core Income
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter
Companies with Upcoming Results
Mutual Funds Increased Shareholding in Past Month
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
Red Flags: Weakening Technicals and Share Price Decline
Rising Delivery Percentage Compared to Prev Day
Expensive Performers (DVM)